In patients with chronic inflammatory rheumatic diseases, non-adherence to methotrexate therapy could lead to lower drug efficacy, unnecessary adjustments of medication, and avoidable health-care costs. Use of a novel blood assay to measure methotrexate could help prevent or reduce non-adherence in clinical practice.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann. Rheum. Dis. 76, 960–977 (2017).
Gossec, L. et al. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. Joint Bone Spine 86, 13–19 (2019).
Bluett, J. et al. Development and validation of a methotrexate adherence assay. Ann. Rheum. Dis. 78, 1192–1197 (2019).
van den Bemt, B. J., Zwikker, H. E. & van den Ende, C. H. M. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev. Clin. Immunol. 8, 337–351 (2012).
Scheiman-Elazary, A. et al. The rate of adherence to antiarthritis medications and associated factors among patients with rheumatoid arthritis: a systematic literature review and metaanalysis. J. Rheumatol. 43, 512–523 (2016).
Curtis, J. et al. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J. Rheumatol. 43, 1997–2009 (2016).
Pasma, A. et al. Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? PLOS ONE 12, e0171070 (2017).
Sokol, M. C. et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med. Care 43, 521–530 (2005).
Lavielle, M. et al. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. RMD Open 4, e000684 (2018).
Costedoat-Chalumeau, N. et al. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann. Rheum. Dis. 72, 1786–1792 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Dougados, M. Could a methotrexate blood assay improve adherence?. Nat Rev Rheumatol 15, 577–578 (2019). https://doi.org/10.1038/s41584-019-0291-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-019-0291-x